ARCHIVES

DCT Board Approves Phase 2/3 Studies Of LAK-IL-2

This article is from The Cancer Letter archive.

Vol. 12 No. 07 | February 14, 1986

Download PDF Visit The Full Archive

Related Articles

DCT Board Approves Drug Development Recompetition

November 30, 1990

Fox Chase-U.Pa. Radiation Dept. Received Contract

October 12, 1979

NCI Contract Awards.

February 18, 2000

Rosenberg’s Adoptive Immunotherapy Update

December 6, 1985

Fewer, Larger RT Doses Cut Recurrence Of Early Breast Cancer, UK Study Finds

June 29, 2007

In Brief: Walter Lawrence, Reginald Ho Lead ACS; Henderson To Leave Dana-Farber for UCSF

November 22, 1991